Veradermics Inc.

02/05/2026 | Press release | Distributed by Public on 02/05/2026 18:04

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Longitude Capital Partners V, LLC
2. Issuer Name and Ticker or Trading Symbol
Veradermics, Inc [MANE]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
2740 SAND HILL ROAD, SECOND FLOOR,
3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026
(Street)
MENLO PARK, CA 94025
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/05/2026 C(1) 1,236,631 A (1) 1,236,631 I See Footnote(2)
Common Stock 02/05/2026 C(3) 1,171,121 A (3) 2,407,752 I See Footnote(2)
Common Stock 02/05/2026 C(3) 1,171,121 A (3) 1,171,121 I See Footnote(4)
Common Stock 02/05/2026 P 192,647 A $17 2,600,399 I See Footnote(2)
Common Stock 02/05/2026 P 882,353 A $17 2,053,474 I See Footnote(4)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series B Convertible Preferred Stock (1) 02/05/2026 C 1,236,631 (1) (1) Common Stock 1,236,631 (1) 0 I See Footnote(2)
Series C Convertible Preferred Stock (3) 02/05/2026 C 1,171,121 (3) (3) Common Stock 1,171,121 (3) 0 I See Footnote(2)
Series C Convertible Preferred Stock (3) 02/05/2026 C 1,171,121 (3) (3) Common Stock 1,171,121 (3) 0 I See Footnote(4)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Longitude Capital Partners V, LLC
2740 SAND HILL ROAD, SECOND FLOOR
MENLO PARK, CA 94025
X
Longitude 103.8 East Partners, LLC
C/O LONGITUDE CAPITAL
2740 SAND HILL ROAD, SECOND FLOOR
MENLO PARK, CA 94025
X
Longitude 103.8 East, L.P.
C/O LONGITUDE CAPITAL
2740 SAND HILL ROAD, SECOND FLOOR
MENLO PARK, CA 94025
X
Longitude Venture Partners V, L.P.
C/O LONGITUDE CAPITAL
2740 SAND HILL ROAD, SECOND FLOOR
MENLO PARK, CA 94025
X

Signatures

/s/ Cristiana Oliveira 02/05/2026
**Signature of Reporting Person Date
/s/ Cristiana Oliveira 02/05/2026
**Signature of Reporting Person Date
/s/ Cristiana Oliveira 02/05/2026
**Signature of Reporting Person Date
/s/ Cristiana Oliveira 02/05/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
(2) These shares are held by Longitude Venture Partners V, L.P. ("LVPV"). Longitude Capital Partners V, LLC ("LCPV"), is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these shares. Juliet Tammenoms Bakker and Patrick Enright, a member of the board of directors of the Issuer, are the managing members of LCPV, and may each be deemed to share voting, investment and dispositive power with respect to these shares. Each of LCPV, Ms. Tammenoms Bakker and Patrick Enright disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
(3) On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
(4) These shares are held by Longitude 103.8 East, L.P. ("L103"). Longitude 103.8 East Partners, LLC ("L103P") is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to these shares. Juliet Tammenoms Bakker and Patrick Enright, a member of the board of directors of the Issuer, are the managing members of L103P, and may each be deemed to share voting, investment and dispositive power with respect to these shares. Each of L103P, Ms. Tammenoms Bakker and Patrick Enright disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Veradermics Inc. published this content on February 05, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 06, 2026 at 00:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]